Coagulopathy after successful cardiopulmonary resuscitation following cardiac arrest: implication of the protein C anticoagulant pathway

J Am Coll Cardiol. 2005 Jul 5;46(1):21-8. doi: 10.1016/j.jacc.2005.03.046.

Abstract

Objectives: We investigated coagulation abnormalities in out-of-hospital cardiac arrest (OHCA) patients, with special attention to the protein C anticoagulant pathway.

Background: Successfully resuscitated cardiac arrest is followed by a systemic inflammatory response and by activation of coagulation, both of which may contribute to organ failure and neurological dysfunction.

Methods: Coagulation parameters were measured in all patients admitted after successfully resuscitated OHCA.

Results: At admission, 67 patients had a systemic inflammatory response with increased interleukin-6 and coagulation activity (thrombin-antithrombin complex), reduced anticoagulation (antithrombin, protein C, and protein S), activated fibrinolysis (plasmin-antiplasmin complex), and, in some cases, inhibited fibrinolysis (increased plasminogen activator inhibitor-1 with a peak on day 1). These abnormalities were more severe in patients who died within two days (50 of 67, 75%) and were most severe in patients dying from early refractory shock. Protein C and S levels were low compared to healthy volunteers and discriminated OHCA survivors from nonsurvivors. Furthermore, a subgroup of patients had a transient increase in plasma-activated protein C at admission followed by undetectable levels. This, along with an increase in soluble thrombomodulin over time, suggests secondary endothelial injury and dysfunction of the protein C anticoagulant pathway similar to that observed in severe sepsis.

Conclusions: Major coagulation abnormalities were found after successful resuscitation of cardiac arrest. These abnormalities are consistent with secondary down-regulation of the thrombomodulin-endothelial protein C receptor pathway.

MeSH terms

  • Aged
  • Antithrombins / metabolism
  • Blood Coagulation Factors / metabolism
  • Cardiopulmonary Resuscitation*
  • Case-Control Studies
  • Female
  • Fibrin Fibrinogen Degradation Products / metabolism
  • Heart Arrest / blood*
  • Heart Arrest / therapy*
  • Humans
  • Male
  • Middle Aged
  • Partial Thromboplastin Time
  • Protein C / metabolism*
  • Protein S / metabolism
  • Thrombin Time
  • Thrombomodulin / blood

Substances

  • Antithrombins
  • Blood Coagulation Factors
  • Fibrin Fibrinogen Degradation Products
  • Protein C
  • Protein S
  • Thrombomodulin
  • fibrin fragment D